相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Lipidomics of hepatic lipogenesis inhibition by omega 3 fatty acids
Antonin Lamaziere et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2013)
Incorporation of eicosapentaenoic and docosahexaenoic acids into lipid pools when given as supplements providing doses equivalent to typical intakes of oily fish
Lucy M. Browning et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2012)
Bioequivalence of two omega-3 fatty acid ethyl ester formulations: a case of clinical pharmacology of dietary supplements
Claudio Galli et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Prevention of 1-palmitoyl lysophosphatidylcholine-induced inflammation by polyunsaturated acyl lysophosphatidylcholine
Nguyen Dang Hung et al.
INFLAMMATION RESEARCH (2012)
Short term effects of different omega-3 fatty acid formulation on lipid metabolism in mice fed high or low fat diet
Xiao Tang et al.
LIPIDS IN HEALTH AND DISEASE (2012)
Fish Oil Supplementation Alters the Plasma Lipidomic Profile and Increases Long-Chain PUFAs of Phospholipids and Triglycerides in Healthy Subjects
Inger Ottestad et al.
PLOS ONE (2012)
Mechanisms for anti-inflammatory effects of 1-[15(S)-hydroxyeicosapentaenoyl] lysophosphatidylcholine, administered intraperitoneally, in zymosan A-induced peritonitis
Nguyen Dang Hung et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Oral Administration of 2-Docosahexaenoyl Lysophosphatidylcholine Displayed Anti-Inflammatory Effects on Zymosan A-Induced Peritonitis
Nguyen Dang Hung et al.
INFLAMMATION (2011)
Activity of essential phospholipids (EPL) from soybean in liver diseases
Karl-Josef Gundermann et al.
PHARMACOLOGICAL REPORTS (2011)
The differential effects of EPA and DHA on cardiovascular risk factors
S. C. Cottin et al.
PROCEEDINGS OF THE NUTRITION SOCIETY (2011)
Moderate doses of EPA and DHA from re-esterified triacylglycerols but not from ethyl-esters lower fasting serum triacylglycerols in statin-treated dyslipidemic subjects: Results from a six month randomized controlled trial
J. P. Schuchardt et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2011)
Metabolism and atherogenic disease association of lysophosphatidylcholine
Gerd Schmitz et al.
ATHEROSCLEROSIS (2010)
Specialized pro-resolving lipid mediators in the inflammatory response: An update
Gerard Bannenberg et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2010)
Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids
Yuriko Adkins et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2010)
Effect of dietary fat on endocannabinoids and related mediators: Consequences on energy homeostasis, inflammation and mood
Sebastiano Banni et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2010)
The Effects of EPA, DHA, and Aspirin Ingestion on Plasma Lysophospholipids and Autotaxin
R. C. Block et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2010)
Maternal dietary fat intake during gestation and lactation alters tissue fatty acid composition in the adult offspring of C57Bl/6 mice
Kanta Chechi et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2010)
Marine phospholipids-a promising new dietary approach to tumor-associated weight loss
Lenka A. Taylor et al.
SUPPORTIVE CARE IN CANCER (2010)
Polyunsaturated fatty acid-cholesterol interactions: Domain formation in membranes
Stephen R. Wassall et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2009)
Resolvins and protectins: mediating solutions to inflammation
Payal Kohli et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Link between plasma ceramides, inflammation and insulin resistance: association with serum IL-6 concentration in patients with coronary heart disease
V. D. F. de Mello et al.
DIABETOLOGIA (2009)
Hepatic lipid metabolism response to dietary fatty acids is differently modulated by PPARα in male and female mice
Anne Morise et al.
EUROPEAN JOURNAL OF NUTRITION (2009)
A Systemic Review of the Roles of n-3 Fatty Acids in Health and Disease
Natalie D. Riediger et al.
JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION (2009)
Lysophosphatidylcholine Exhibits Selective Cytotoxicity, Accompanied by ROS Formation, in RAW 264.7 Macrophages
Cheon Ho Park et al.
LIPIDS (2009)
Lipids as targets for novel anti-inflammatory therapies
Andrea Huwiler et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Lipid signalling in disease
Matthias P. Wymann et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Dietary n-3 polyunsaturated fatty acids and endothelium dysfunction induced by lysophosphatidylcholine in Syrian hamster aorta
Anthony Lucas et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2008)
Gender differences in the n-3 fatty acid content of tissues
Caroline E. Childs et al.
PROCEEDINGS OF THE NUTRITION SOCIETY (2008)
Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake
Leanne Hodson et al.
PROGRESS IN LIPID RESEARCH (2008)
Basic mechanisms behind the effects of n-3 fatty acids on cardiovascular disease
Marika Massaro et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2008)
Anti-inflammatory effects of phosphatidylcholine
Irina Treede et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Modulation of inflammation in brain: a matter of fat
Akhlaq A. Farooqui et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Role of lipoprotein-associated phospholipase A2 in leukocyte activation and inflammatory responses
Yi Shi et al.
ATHEROSCLEROSIS (2007)
Evaluation of the effect of Neptune Krill Oil on chronic inflammation and arthritic symptoms
Luisa Deutsch
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2007)
Lysophosphatidylcholine induces inflammatory activation of human coronary artery smooth muscle cells
Nambi Aiyar et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2007)
Resolvins and protectins in the termination program of acute inflammation
Amirarn Ariel et al.
TRENDS IN IMMUNOLOGY (2007)
Apoptosis in skeletal muscle myotubes is induced by ceramides and is positively related to insulin resistance
Sarah M. Turpin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
The phosphatidylcholine/lysophosphatidylcholine ratio in human plasma is an indicator of the severity of rheumatoid arthritis:: Investigations by 31P NMR and MALDI-TOF MS
B Fuchs et al.
CLINICAL BIOCHEMISTRY (2005)
Lysophospholipids enhance matrix metalloproteinase-2 expression in human endothelial cells
WT Wu et al.
ENDOCRINOLOGY (2005)
Membrane effects of the n-3 fish oil fatty acids, which prevent fatal ventricular arrhythmias
A Leaf et al.
JOURNAL OF MEMBRANE BIOLOGY (2005)
Shotgun lipidomics: Electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples
XL Han et al.
MASS SPECTROMETRY REVIEWS (2005)
Suppression of HMGB1 release by stearoyl lysophosphatidylcholine: an additional mechanism for its therapeutic effects in experimental sepsis
GQ Chen et al.
JOURNAL OF LIPID RESEARCH (2005)
Dietary fats and membrane function: implications for metabolism and disease
AJ Hulbert et al.
BIOLOGICAL REVIEWS (2005)
Marine n-3 polyunsaturated fatty acids and coronary heart disease - Part I. Background, epidemiology, animal data, effects on risk factors and safety
EB Schmidt et al.
THROMBOSIS RESEARCH (2005)
Therapeutic effects of lysophosphatidylcholine in experimental sepsis
JJ Yan et al.
NATURE MEDICINE (2004)
n-3 fatty acids and cardiovascular disease: evidence explained and mechanisms explored
PC Calder
CLINICAL SCIENCE (2004)
Identification of α-chloro fatty aldehydes and unsaturated lysophosphatidylcholine molecular species in human atherosclerotic lesions
AK Thukkani et al.
CIRCULATION (2003)
The role of liver X receptor-α in the fatty acid regulation of hepatic gene expression
A Pawar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Vascular remodeling induced by naturally occurring unsaturated lysophosphatidic acid in vivo
K Yoshida et al.
CIRCULATION (2003)
Unsaturated fatty acid regulation of peroxisome proliferator-activated receptor α activity in rat primary hepatoctes
A Pawar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils
A Leaf et al.
CIRCULATION (2003)
Docosahexaenoic acid: membrane properties of a unique fatty acid
W Stillwell et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2003)
Cooperation between secretory phospholipase A2 and TNF-receptor signaling -: Implications for, the inflammatory response in atherogenesis
L Fuentes et al.
CIRCULATION RESEARCH (2002)
Polyunsaturated fatty acids suppress sterol regulatory element-binding protein 1c promoter activity by inhibition of liver X receptor (LXR) binding to LXR response elements
T Yoshikawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Phenotypic modulation of vascular smooth muscle cells induced by unsaturated lysophosphatidic acids
K Hayashi et al.
CIRCULATION RESEARCH (2001)
Lysophosphatidylcholine as a preferred carrier form of docosahexaenoic acid to the brain
M Lagarde et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2001)
Dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia
J Goodfellow et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)